Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease

Experimental Neurology

Volumn 160, Issue 1, 1999, Pages 194-204

  Ikonomovic, Milos D ^a   Mizukami, Katsuyoshi ^a,b   Warde, Deirdre ^a   Sheffield, Roxanne ^a   Hamilton, Ronald ^c   Wenthold, Robert J ^d   Armstrong, David M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^d NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Alzheimer's disease; Excitotoxicity; Glutamate; Hippocampus; Immunohistochemistry; Receptors

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; FEMALE; GRANULE CELL; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SUBICULUM;

EID: 0032710970     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7196     Document Type: Article

References (34)

1. Armstrong D. M., LeRoy S. L., Shields D., Terry R. D. Somatostatin-like immunoreactivity within neuritic plaques. Brain Res. 338:1985a;71-79.
2. Armstrong D. M., Terry R. D. Substance-P immunoreactivity within plaques. Neurosci. Lett. 58:1985b;139-145.
3. Armstrong D. M., Bruce G., Hersh L. B., Terry R. D. Choline acetyltransferase immunoreactivity within senile plaques of patients with Alzheimer's disease. Neurosci. Lett. 71:1986;229-234.
4. Armstrong D. M., Benzing W. C., Hansen L. B., Shields D., Evans J. Substance P and somatostatin coexist within senile plaques of patients with Alzheimer's disease. Neuroscience. 31:1989;663-671.
5. Armstrong D. M., Ikonomovic M. D., Sheffield R., Wenthold R. J. AMPA-selective glutamate receptor subtype immunoreactivity in the entorhinal cortex of non-demented elderly and patients with Alzheimer's disease. Brain Res. 639:1994;207-216.
6. Armstrong D. M., Ikonomovic M. D. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer's disease. Mol. Chem. Neuropathol. 28:1996;59-64.
7. Blumcke I., Beck H., Scheffler B., Hof P. R., Morrison J. H., Wolf H. K., Schramm J., Elger C. E., Wiestler O. D. Altered distribution of the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit GluR2-(4) and N-methyl-D-aspartate receptor subunit NMDAR1 in the hippocampus of patients with temporal lobe epilepsy. Acta Neuropathol. 92:1996;576-587.
8. Bockers T. M., Zimmer M., Muler A., Bergmann M., Brose N., Kreutz M. R. Expression of the NMDAR1 receptor in selected human brain regions. Neuroreport. 5:1994;965-969.
9. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
10. Cowburn R., Hardy J., Roberts P., Briggs R. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease. Brain Res. 452:1988;403-407.
11. Gazzaley A. H., Siegel S. J., Kordower J. H., Mufson E. J., Morrison J. H. Circuit-specific alterations of N-methyl-D-aspartate receptor subunit in the dentate gyrus of aged monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;3121-3125.
12. Gazzaley A. H., Thakker M. M., Hof P. R., Morrison J. H. Preserved number of entrorhinal cortex layer II neurons in aged macaque monkeys. Neurobiol. Aging. 18:1997;549-553.
13. Geddes J. W., Chang Chui H., Cooper S. M., Lott I. T., Cotman C. W. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res. 399:1986;156-161.
14. Gomez-Isla T., Price J. L., McKeel D. W. Jr, Morris J. C., Growdon J. H., Hyman B. T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16:1996;4491-4500.
15. 3H]glutamate binding. J. Neurochem. 48:1987;543-551.
16. Hof P. R., Vissavajjhala P., Rosenthal R. E., Fiskum G., Morrison J. H. Distribution of glutamate receptor subunit proteins GluR2(4), GluR5/6/7, and NMDAR1 in the canine and primate cerebral cortex: A comparative immunohistochemical analysis. Brain Res. 723:1996;77-89.
17. 2+ permeability of KA-AMPA-gated glutamate channels depends on subunit composition. Science. 252:1991;851-853.
18. Hyman B. T., Van Hoesen G. W., Damasio A. R., Barnes C. L. Alzheimer's disease: Cell specific pathology isolates the hippocampal formation in Alzheimer's disease. Science. 225:1984;1168-1170.
19. Hyman B. T., Penney J. B. Jr., Blackstone C. D., Young A. B. Localization of non-N-methyl-D-aspartate glutamate receptors in normal and Alzheimer hippocampal formation. Ann. Neurol. 35:1994;239-252.
20. Ikonomovic M. D., Sheffield R., Armstrong D. M. AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation. J. Comp. Neurol. 359:1995a;239-252.
21. Ikonomovic M. D., Sheffield R., Armstrong D. M. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease. Hippocampus. 5:1995b;469-486.
22. Ikonomovic M. D., Armstrong D. M. Distribution of AMPA receptor subunits in the nucleus basalis of Meynert in aged humans: Implications for selective neuronal degeneration. Brain Res. 716:1996;229-232.
23. Ikonomovic M. D., Mizukami K., Davies P., Hamilton R., Sheffield R., Armstrong D. M. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer's brains. J. Neuropathol. Exp. Neurol. 56:1997;1018-1027.
24. Jansen K. L. R., Faull R. L. M., Dragunow M., Synek B. L. Alzheimer's disease: Changes in hippocampal N-methyl-D-apartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors- and autoradiographic study. Neuroscience. 39:1990;613-627.
25. 3H]TCP binding in Alzheimer's disease. Neurosci. Lett. 74:1987;371-376.
26. Mirra S. S., Heyman A., McKeel D., Sumi S. M., Crain B. J., Brownlee L. M., Vogel F. S., Hughes J. P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
27. 3H]TCP binding sites in Alzheimer's disease. Neurosci. Lett. 73:1987;197-200.
28. Penney J. B., Maragos W. F., Greenamyre J. T., Debowey D. L., Hollingsworth Z., Young A. B. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias. J. Neurosci. Neurosurg. Psychol. 53:1990;314-320.
29. Petralia R. S., Yokotani N., Wenthold R. J. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J. Neurosci. 14:1994;667-696.
30. Procter A. W., Stirling J. M., Stratmann G. C., Cross A. J., Bowen D. M. Loss of glycine-dependent radioligand binding to the N-methyl-D-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease. Neurosci. Lett. 101:1989;62-66.
31. Siegel S. J., Janssen W. G., Tullai J. W., Rogers S. W., Moran T., Heinemann S. F., Morrison J. H. Distribution of the excitatory amino acid receptor subunits GluR2(4) in monkey hippocampus and colocalization with subunits GluR5-7 and NMDAR1. J. Neurosci. 15:1995;2707-2719.
32. Siegel S. J., Brose N., Jansse W. G., Gasic G. P., Jahn R., Heinemann S. F., Morrison J. H. Region, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proc. Natl. Acad. Sci. USA. 91:1994;564-568.
33. Su J. H., Cummings B. J., Cotman C. W. Identification and distribution of axonal dystrophic neurites in Alzheimer's disease. Brain Res. 625:1993;229-237.
34. Ulas J., Brunner L. C., Geddes J. W., Choe W., Cotman C. W. N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease. Neuroscience. 49:1992;45-61.